CoreAge Rx and Mochi both market online access to care that may involve compounded tirzepatide. Their advertised payment structures differ, but an accurate comparison also needs the prescription, pharmacy, and follow-up arrangement.
We compared the published offer and fee records on October 5, 2026. This article reads billing, prescription and care arrangements; it does not describe a clinical head-to-head test or personal treatment results.
The most useful comparison is two complete written offers for clinically appropriate care, not two starting prices.
Compare the same billing period
CoreAge’s supplied twelve-month tirzepatide quote is $129 per month, or $1,548 across the term. Its public product page separately shows $149. Confirm the selected offer, first payment and actual supply schedule. Mochi’s FAQ lists $79 for one month of membership and compounded tirzepatide from $90, dependent on the prescribed dose.
Mochi’s two recurring starting figures add to $169 as an illustration, not a final individual quote; a first-month promotion or longer membership can change the payment. Compare like periods and obtain the medicine, visit, labs, supplies and shipping together. Our cost fieldnote keeps those questions in one place.
Sources: CoreAge Rx: Tirzepatide product page · CoreAge Rx: Current promotional offer · Mochi Health: Public care and pricing FAQs
Ask what access to care actually means
CoreAge describes clinical intake review and ongoing provider access. Mochi describes video visits, messaging, and plan-dependent support services. Those public descriptions do not establish the same appointment format, response time, or nutrition services.
Ask each service who will prescribe, when follow-up occurs, how urgent questions are handled, and what additional visits cost. If nutrition support matters to you, ask which professional provides it in the exact plan you are buying. Read the fuller CoreAge review and Mochi review for the source boundaries.
Sources: CoreAge Rx: Tirzepatide product page · Mochi Health: Public care and pricing FAQs
Do not treat compounded prescriptions as identical
Neither a shared ingredient nor similar marketing proves that two compounded preparations are equivalent. Ask for the formulation, concentration, pharmacy, storage requirements, and medical reason an approved product would not meet your needs.
CoreAge says it assigns a pharmacy after clinical review. For either service, verify the pharmacy actually handling your prescription and its relevant licensing. FDA’s compounding concerns deserve attention regardless of which company’s checkout looks simpler.
Sources: CoreAge Rx: Dispensing pharmacy FAQ · FDA: Concerns with unapproved GLP-1 drugs · FDA: Buying medicines from online pharmacies · FDA: GLP-1 supply and compounding policy
Read the exit conditions as carefully as the entry offer
Ask when recurring charges occur, how cancellation works, and what happens to an order already being prepared. Mochi’s public policy says prescription sales are final. Obtain the current order-specific rules from both services before paying, especially for a prepaid plan.
If an approved product is medically suitable, include that option in the clinical discussion rather than limiting research to these two brands. The LillyDirect review provides another route to investigate. Our notebook turns these comparison points into questions you can bring to a visit.
CoreAge’s policy has a possible $50–$100 non-refundable assessment fee, finality after pharmacy transmission and a 30-day order cutoff. The full CoreAge policy review explains those exceptions. To widen the reading beyond this two-provider comparison, see the SuperHealthy review and Likeness review.
Sources: Mochi Health: Refunds · Mochi Health: Terms · FDA: Managing medicine benefits and risks · LillyDirect: Zepbound self-pay options · CoreAge Rx: returns, refunds and subscription policy
The source shelf
- CoreAge Rx: Tirzepatide product page
Product page read October 5, 2026: $149 starting figure. The separate $129 annual quote was supplied to this publication; an individual checkout was not tested.
- CoreAge Rx: Current promotional offer
External offer link. The supplied $129 monthly equivalent concerns a 12-month tirzepatide quote ($1,548 total), not a claim that this page currently displayed that figure. Confirm selected checkout.
- Mochi Health: Public care and pricing FAQs
FAQ checked October 5, 2026. $79 one-month membership and compounded tirzepatide from $90, dependent on dose; these are separate fees. Promotional membership offers may differ.
- CoreAge Rx: Dispensing pharmacy FAQ
Provider description of pharmacy matching; actual dispensing pharmacy must be confirmed for an order.
- FDA: Concerns with unapproved GLP-1 drugs
Current FDA page read October 5, 2026. Compounding, dose and ingredient concerns; individual medical need does not establish automatic eligibility or equivalence.
- FDA: Buying medicines from online pharmacies
Checks for prescription requirements, licensing, contact details and pharmacy support.
- FDA: GLP-1 supply and compounding policy
Shortage resolution and restrictions on essentially copies; availability requires current professional assessment.
- Mochi Health: Refunds
Cancellation and refund rules can differ for membership and a processed prescription.
- Mochi Health: Terms
Platform payment and service terms; read with the selected treatment agreement.
- FDA: Managing medicine benefits and risks
General questions for clinical decision-making and medication follow-up.
- LillyDirect: Zepbound self-pay options
Manufacturer page checked October 5, 2026: $299 starting self-pay figure for the starting strength, with presentation, supply-period, eligibility and refill-timing conditions. Not an all-strength price.
- CoreAge Rx: returns, refunds and subscription policy
Primary policy read October 5, 2026. Assessment fees, pharmacy transmission and a 30-day order cutoff limit refunds; policy execution was not tested.
